1 / PRNewswire / -- Boston Scientific Corporation ( NYSE : BSX ) today announced final results from the landmark MADIT-CRT trial , which were published by the New England Journal of Medicine and presented during a Hot Line session at the annual European Society of Cardiology ( ESC ) Congress in Barcelona .